Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment.

Dugosh, Karen L; Lent, Michelle R; Burkley, S Brook; Millard, Conor M K; McKay, James R; Kampman, Kyle M

Dugosh, Karen L; Lent, Michelle R; Burkley, S Brook; Millard, Conor M K; McKay, James R; Kampman, Kyle M.

Affiliation

Dugosh KL; From the Research and Evaluation Group, Public Health Management Corporation, Philadelphia, PA (KLD, SBB, CMKM); School of Professional and Applied Psychology, Philadelphia College of Osteopathic Medicine, Philadelphia, PA (MRL); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (JRM, KMK).

J Addict Med ; 17(5): 612-614, 2023.

Article in En | MEDLINE | ID: mdl-37788620

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Buprenorphine / Cocaine / Opioid-Related Disorders Type of study: Risk_factors_studies Limits: Humans Language: En Journal: J Addict Med Year: 2023 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google